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Abstract
Background: Equine dysautonomia (ED) causes degeneration and loss of autonomic
neurons. Approximately 50% of chronic cases recover, but it is unclear how they sur-
vive neuronal loss.
Objectives: To assess lesions, autonomic neuron numbers, interstitial cells of Cajal
(ICC), and neurodegeneration in recovered cases.
Animals: Thirteen cases (group ED), euthanized 10.3 ± 5.2 (1–16) years from diagno-
sis and 6 age-matched controls (group C).
Methods: Prospective, case control; routine post mortem examination, neuron
counts in peripheral and enteric ganglia and immunohistochemical assessment of
neural networks (Protein gene product [PGP] 9.5), ICC (c-kit), and neurodegeneration
(beta-amyloid precursor protein and ubiquitin) in intestine.
Results: Postmortem findings in group ED were small intestinal dilation (4/12, 33%)
and muscular hypertrophy (4/12, 33%), and gastric mucosal hypertrophy (3/11, 27%)
and ulceration (4/11, 36%). Neuron density was lower in group ED (mean 39% lower
for cranial cervical ganglion [P < .001], median 44% lower in celiacomesenteric ganglion
[P = .01]). In intestine, neuronal depletion was worst in ileum (median 100% lower in
submucosal plexus [P < .001], 91% lower in myenteric plexus [P = .004]). Group ED
had less PGP 9.5 staining in ileal myenteric plexus (mean 66% lower [P = .04]) and cir-
cular muscle (median 75% lower [P = .006]). In ileum, there was less c-kit staining in
myenteric plexus (median 57% lower [P = .02]) but not muscularis externa. Beta-amyloid
precursor protein and ubiquitin results were not indicitive of neurodegeneration.
Conclusions and Clinical Importance: Intact ICC in muscularis externa might help
maintain motility after neuronal loss. Treatment supporting ICC function warrants
investigation.
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BAPP, c-kit, dysautonomia, grass sickness, horse, interstitial cells of Cajal, intestinal motility,
PGP 9.5, ubiquitin
Abbreviations: BAPP, beta-amyloid precursor protein; CCG, cranial cervical ganglion; CM, circular muscle; CMG, celiacomesenteric ganglion; ED, equine dysautonomia; HE, hematoxylin and
eosin; IHC, immunohistochemistry; LM, longitudinal muscle; LVC, left ventral colon; MP, myenteric plexus; PGP 9.5, protein gene product 9.5; SC, small colon; SMP, submucosal plexus.
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1 | INTRODUCTION
Equine dysautonomia (ED; equine grass sickness) is a commonly fatal dis-
ease of horses characterized by autonomic nervous system dysfunction.
It occurs predominantly in northern Europe1 and South America.2 The
cause is unknown, although current theories include toxicoinfection with
Clostridium botulinum type C3 or a pasture-derived mycotoxicosis.1,4
Pathological changes include neuronal degeneration in the autonomic
ganglia, enteric nervous system, brainstem, and spinal cord nuclei.5-7
Although acute and subacute ED are fatal, over 50% of chronic cases
can survive with supportive management.8 Clinical signs of acute and
subacute ED include gastrointestinal stasis, dysphagia, and nasogastric
reflux. Impaired gastrointestinal motility can also be present in chronic
ED but does not cause complete stasis and such cases present with
cachexia, mild colic, dysphagia, and hyporexia. Many survivors return to
work after many months; however, some retain long-term residual defi-
cits, including mild dysphagia and recurrent colic.9,10
In chronic ED, the number of neurons in prevertebral and para-
vertebral ganglia11 and enteric plexuses6,12 is lower than in acute ED,
and loss is most severe in the ileum.6,10 However, the means by which
chronic cases survive despite neuronal depletion is not established.
More recently, attention has turned to the interstitial cells of Cajal
(ICC), a cellular network present mainly in the intestinal muscularis
externa and myenteric plexus (MP). Interstitial cells of Cajal are consid-
ered to have a pacemaker function in initiating slow wave activity.13
Although ICC numbers are reduced in ED, this reduction was signifi-
cantly less in circular muscle (CM) of chronic compared with acute
cases14 and in vitro electrical activity can still be prominent in chronic
ED, suggesting that ICC-associated pacemaker activity remains intact
despite neuronal loss, although that study did not examine recovered
cases.15 This was supported by the study of a long-term recovered
case with severe neuronal loss in ganglia and ileal plexuses but an
apparently intact network of ICC in the MP and CM.16
The number of chromatolytic neurons in recovered cases is small
on standard histological examination.10 However, it remains unclear
whether more subtle evidence of neuronal dysfunction might be rev-
ealed through the assessment of various marker proteins, known to
change in human neurodegenerative diseases and acute and subacute
ED. There is an increase in beta-amyloid precursor protein (BAPP), a
protein associated with misfolding/aggregation, and changes in intra-
cellular localization of ubiquitin (ubiquitin carboxy-terminal hydrolase
L1) which regulates protein misfolding, in the neurons of acute and
subacute ED cases.17-19 Expression of these proteins in long-term sur-
vivors has not yet been studied.
The objectives of the present study were to determine the gross
lesions, quantify the degree of neuronal depletion in the ganglia and
enteric plexuses, determine the extent of the ICC network, and quan-
tify markers of neurodegeneration in long-term recovered cases of ED
in order to better understand how horses can recover. It was hypothe-
sized that the ICC might help maintain intestinal function when mar-
ked neuronal depletion is present in recovered cases, but that
evidence of ongoing neurodegeneration would be minimal.
2 | MATERIALS AND METHODS
2.1 | Animals
In this prospective study, inclusion criteria for ED cases consisted of a
diagnosis made on the basis of detailed clinical examinations by expe-
rienced clinicians at the Equine Hospital, at least 1 year between diag-
nosis and euthanasia, availability of at least 2 tissues (including the
ileum and at least 1 prevertebral or paravertebral ganglion), and clear
post mortem histological evidence of neuronal loss in the ileum typical
of chronic ED on standard hematoxylin and eosin (HE) staining. Ante-
mortem diagnosis by invasive intestinal biopsy was not undertaken as
this is considered to adversely affect outcome in some cases,9 and in
view of the typical clinical signs, it was not considered necessary.
Recovery was defined as an increase to normal (or near normal)
weight, lack of, or marked improvement in clinical signs so that nurs-
ing was no longer required, and ability to undertake exercise (mainly
ridden work). Cases were excluded if they did not meet these criteria
or if autolysis was advanced. Controls comprised 6 age-matched
horses euthanized at the Equine Hospital for reasons unconnected
with ED, gastrointestinal or neurological disease. The study was
approved by the local Veterinary Ethical Review Committee (approval
no. 118/15), and owner consent was obtained for inclusion of their
animals in the study. All horses were euthanized on the basis of clini-
cal need and not solely for the purpose of the study. Euthanasia was
carried out by barbiturate overdose.
2.2 | Postmortem examination and tissue collection
All cases and controls were subjected to full gross postmortem exami-
nation at the Veterinary Pathology Unit on the day of euthanasia and
usually immediately after death. In 1 additional case (ED10), tissues
were supplied by the primary care veterinarian and had been collected
the day after euthanasia. A gross description was recorded. Intestinal
dilation was defined as increased diameter with a turgid wall and was
considered distinct from dilation occurring due to antemortem or post-
mortem gas accumulation. Esophageal and intestinal muscular hyper-
trophy was defined as thickening of the muscularis externa compared
with adjacent areas of the organ and in comparison with the expected
normal appearance. Whenever possible, tissues collected were cranial
cervical ganglion (CCG), thoracic sympathetic chain intervertebral gang-
lia, celiacomesenteric ganglion (CMG), jejunum, ileum, left ventral large
colon (LVC), and small colon (SC); however, for various reasons, not all
tissues were available for every case. In some cases, esophagus, stom-
ach (margo plicatus), duodenum, cecum, pelvic flexure of the large colon,
rectum, adrenal gland, pituitary gland, brain, spinal cord, triceps muscle,
bladder, liver, heart, kidney, and spleen were also collected.
2.3 | Routine histopathology
Tissues were placed in 10% phosphate-buffered formalin (pH 7.4)
until fixed, then processed to paraffin wax blocks, from which 4 μm
thick sections were cut and stained with HE using standard
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techniques. Whenever possible, intestinal tissues were oriented, so
sections were cut parallel to the long axis of the CM smooth muscle
cells. The HE sections were used to assess general pathological and
artefactual changes, to assess neuron morphology, and to count neu-
rons in the CCG, CMG, jejunum, ileum, LVC, and SC. The slides were
scanned in a Nanozoomer slide scanner (Hamamatsu Ltd, Welwyn
Garden City, United Kingdom). Using the scanned images of CCG and
CMG, 4 random 1 mm2 were created and the average number of neu-
rons per mm2 counted using ImageJ software (National Institutes of
Health). Random images were used to allow for the fact that neurons
are not uniformly distributed in ganglia. In the sections from the
4 parts of the intestine, the length of the section was instead mea-
sured on the scanned slide and the number of neurons per centimeter
counted separately for the submucosal plexus (SMP) and MP from the
original glass slides on which small neurons were more easily identi-
fied using an Olympus BX51 microscope (Olympus Ltd, Southend-on-
Sea, United Kingdom).
2.4 | Immunohistochemistry
Immunohistochemistry was carried out on fixed paraffin wax-embedded
sections (4 μm) on SuperFrost Plus coated slides (Thermo Electron;
Runcorn, Cheshire, United Kingdom) that were dewaxed and rehydrated.
For protein gene product 9.5 (PGP 9.5), the primary antibody was rab-
bit anti-human polyclonal antibody Clone UCHL1 (Cat no 7863-0504;
Bio-Rad, Kidlington, United Kingdom) diluted 1/2000. After incubation
at 4C overnight, secondary antibody (goat anti-rabbit HRP 1/50, Cat
no PI-1000; Vector Laboratories, Peterborough, United Kingdom) was
applied and incubated for 30 minutes followed by visualization with a
commercial immunolabeling kit (DakoCytomation EnVision+ System-
HRP, DAB K4001; Dako, Ely, United Kingdom). Beta-amyloid precursor
protein staining was carried out after high pH antigen retrieval over-
night at 60C. Primary antibody was monoclonal mouse anti-APP A4
clone 22C11 (Cat no MAB348, Merck), diluted 1/16000 and incubated
for 120 minutes at room temperature followed by incubation with anti-
mouse antibody-HRP (EnVision+, Dako) for 40 minutes and visualiza-
tion with DAB. For c-kit, antigen retrieval was carried out using 0.01 M
citrate pH 6.0 at 110C for 5 minutes. The primary antibody (rabbit
polyclonal anti-CD117, Cat no A4502, Dako) was diluted 1/200
and incubated overnight at 4C followed by anti-rabbit antibody-HRP
(EnVision+; Dako) for 40 minutes and visualization with DAB. For
ubiquitin, antigen retrieval was carried out using citrate buffer pH 6 at
110C for 5 minutes. The primary antibody (monoclonal mouse anti-
body, clone Ubi-1, Cat no MAB1510; Millipore, Watford, Hertfordshire,
United Kingdom) was diluted 1/35000, and sections were incubated for
30 minutes at room temperature. This was followed by incubation for
40 minutes at room temperature with secondary antibody (anti-mouse
antibody-HRP, EnVision+; Dako) and visualization with DAB. All sec-
tions were counterstained with hematoxylin. The immunohistochemistry
(IHC) methods have been previously validated for equine tissues in our
laboratory.16,18,19
The method of analyzing the results of IHC in intestine was cho-
sen based on the stain, site, and morphology of the stained areas. The
slides of jejunum, ileum, LVC, and SC stained with PGP 9.5 and c-kit
were scanned in the Nanozoomer scanner. Two random x100 images
of well-oriented, straight regions (covering most of the well-oriented
areas) were taken of each of the MP, CM, and for ileum only, the lon-
gitudinal muscle (LM), and the percentage area stained was deter-
mined for each image to calculate the average percentage area
stained per site, using ImageJ software. This was accomplished by
splitting the image, selecting the blue channel, and converting it into
binary for particle analysis. The threshold was set by comparison of
multiple typical images with the original IHC and was kept at the same
level for all images for each stain. Longitudinal muscle was only
assessed in the ileum due to the small amount of staining and thinness
of the muscle layer in the other parts of the intestine. For the MP, the
2 x100 images were created by marking and cropping a rectangle
along the length and width of the MP, in random areas with straight
orientation of the MP, similar to a method previously described.20 The
SMP was not studied for PGP 9.5 or c-kit due to minimal staining and
artefactual disruption of the loose submucosal connective tissue
preventing reliable assessment per unit area.
Beta-amyloid precursor protein staining of neurons and axons
was assessed semi-quantitatively as the percentage stained and
intensity of staining in the CCG, thoracic chain, and CMG, and in the
SMP and MP of the jejunum, ileum, LVC, and SC as follows: %posi-
tive: 0 = completely negative, 1 = 1%-25% of cells positive, 2 = 26%-
50% positive, 3 = 51%-75% positive, and 4 = >75% positive; intensity
score of neurons: negative (0), weakly positive (1), moderately posi-
tive (2), and strongly positive (3); intensity score of axons; negative
(0), moderately positive (1), and strongly positive (2).
Ubiquitin staining was assessed separately in the cytoplasm and
nucleus of neurons in the CCG, thoracic chain, and CMG, and in the
SMP and MP of the jejunum, ileum, LVC, and SC, including the SMP
and MP of the 4 intestinal tissues. The intensity score in the cytoplasm
and nucleus of neurons and in axons was classified as negative (0),
weakly positive (1), moderately positive (2), and strongly positive (3).
Semi-quantitative staining for BAPP and ubiquitin was carried out in
preference to image analysis as intensity of staining is not linear using
DAB-based visualization. Beta-amyloid precursor protein and ubiquitin
slides were examined blind and scored twice on different days by the
same pathologist (E.M.) for consistency. Unlike for c-kit and PGP 9.5,
assessment of BAPP and ubiquitin was possible in the SMP despite
artefactual disruption, because the assessment was based on morphol-
ogy of individual neurons rather than percentage area positively stained.
2.5 | Statistics
All results were assessed for normality using the Ryan-Joiner test. The
neuron counts and IHC score results were compared between ED and
control groups for each measurement using unpaired t tests for para-
metric data and the Mann-Whitney U test for nonparametric data.
Statistical analysis was carried out using Minitab v17 (Minitab Ltd,
Coventry, United Kingdom), and statistical significance was set at
P ≤ .05. The main data analyses that are not presented in the manu-
script are available in the Supporting Information.
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3 | RESULTS
3.1 | Animals
An adequate range of tissues was available from 13 horses considered
to have recovered from ED. These were obtained postmortem between
2002 and 2017. In 1 (ED10), only neuron counts could be carried out
as autolysis decreased the quality of IHC.
The horses in the ED group consisted of 10 neutered males and
3 females of various breeds; the age at euthanasia was 15.3 ± 4.8
(mean ± SD) years (range 7-20 years), and the time between onset
and euthanasia was 10.3 ± 5.2 years (1-16 years). Group C comprised
2 neutered males and 4 females of several breeds, and the mean age
at euthanasia was 19.3 ± 6.6 years (10-28 years). There was no signif-
icant difference between the ages of groups ED and C (P = .20).
Details of signalment are shown in Supplementary Table 1. All ED
cases had shown typical clinical signs of ED at the onset. In the period
shortly before euthanasia, the main clinical sign in the 9 cases for
which information was available was recurrent colic (3/9), and the
owners requested euthanasia for that reason. However, it should be
noted that recurrent colic had not been a major feature until then. All
other cases were euthanized for a variety of reasons unrelated to ED,
and some had performed at a high level of athleticism including racing
and eventing (Supplementary Table 2).
3.2 | Gross findings and histopathology
The main findings relating to the digestive tract on gross postmortem
and histological examination are presented in Supplementary Table 2.
These were dilation (4/12, 33%) and muscular hypertrophy (4/12,
33%) of the small intestine, especially the distal jejunum and the ileum,
and gastric mucosal hypertrophy (3/11, 27%) and ulceration (4/11,
36%). Of 6/12 (50%) horses with either dilation or muscular hypertro-
phy of the small intestine, 3 had a history of recurrent colic, 2 had no
history of colic, and in 1, the clinical signs were unknown. Liver
changes included mild periportal infiltration, mainly with small lym-
phocytes (4/7 ED cases), but this was also present in 3 of 6 controls.
No abnormalities were evident in other sites other than those related
to the reason for euthanasia (eg, laminitis, arthritis). In group C, there
were no gross or microscopic gastrointestinal tract abnormalities of
importance. The neurons in the CCG, thoracic chain, and CMG of
group ED appeared subjectively depleted on routine assessment, but
chromatolytic neurons were rare; there was a corresponding increase
in support cells and trabecular structures (Figure 1A). No abnormali-
ties were detected in the ganglia in group C (Figure 1B) apart from
occasional chromatolytic neurons.
3.3 | Neuron counts
The neuron counts in the CCG, CMG, and the SMP and MP of the
jejunum, ileum, LVC, and SC are presented in Figures 2 and 3, and
Supplementary Table 3. The number of neurons in the CCG and CMG
was significantly lower in the ED group (mean 39% lower in the CCG
[P < .001] and median 44% lower in the CMG [P = .011]). This
supported the original diagnosis and confirmed that full regeneration
had not occurred. The ileum was the worst affected part of the intes-
tine with markedly reduced neuronal numbers in the SMP and MP
(median 100% lower in the SMP [P < .001] and 91% lower in the MP
[P = .004]). In the SMP and MP, 11 of 13 (85%) and 3 of 13 (23%)
cases had ≤1 neuron per centimeter, respectively. The jejunum was
affected to a lesser degree with significantly lower numbers in the
SMP only (median 59% lower [P = .02]). Neuron numbers in the large
intestine were not significantly different from controls.
3.4 | Immunohistochemistry
When sections were stained for PGP 9.5 for nerve networks, the per-
centage area stained in the MP (mean 66% lower [P = .04]) and CM
(median 75% lower [P = .006]) of the ileum was significantly less in ED
cases compared to controls (Figure 1C, D and Supplementary Table 4).
No significant difference was evident in the LM of the ileum or the MP
or CM of the jejunum, LVC or SC in ED cases compared with controls.
The results of staining for c-kit to demonstrate the ICC are pres-
ented in Figures 4 and 5 and Supplementary Table 5. The ICC in the
ileum were significantly lower in group ED than the controls in the MP
(median 57% lower [P = .02]) but not the CM or LM. The ICC were also
significantly depleted in the MP (median 42% lower [P = .04]) and CM
(mean 66% lower [P = .003]) of the SC compared to control cases.
There was evidence for apparently intact networks of ICC in the
muscularis externa, with cytoplasmic extensions running parallel to the
smooth muscle cells (Figure 1E, F).
In the jejunum and ileum, nuclear staining intensity for ubiquitin
was lower in the SMP and MP in ED compared to control cases (jeju-
nal SMP [P = .03], jejunal MP [P = .03], ileal SMP [P = .04], and ileal
MP [P = .03]; Supplementary Table 6).There were no significant differ-
ences in nuclear or cytoplasmic staining for ubiquitin in the CCG, tho-
racic chain, CMG, or the SMP or MP of the LVC or SC in group ED
compared with group C (Figure 6A, B).
Beta-amyloid precursor protein staining (percentage of neurons sta-
ined and intensity of staining) was not significantly higher in the ganglia
(Figure 6C, D) or the MP or SMP of the jejunum, ileum, LVC, or SC of
ED cases compared with controls. In contrast, the percentage of neu-
rons stained and intensity of BAPP staining in the SMP of the ileum
were significantly lower in ED cases (percentage stained, P = .03, inten-
sity of staining, P = .03). There was no significant difference between
the groups for BAPP staining of axons (Supplementary Table 6).
As some tissue blocks from the ED cases were up to 16 years old,
it was initially considered that prolonged storage might have affected
the IHC staining, but no correlation was found between the age of
block and intensity of staining (data not shown).
4 | DISCUSSION
The major findings in this study were that in long-term recovered ED
cases, gross postmortem findings included small intestinal dilation and
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F IGURE 1 Celiacomesenteric ganglion (CMG) from case ED6 with a reduced density of neurons, hematoxylin and eosin (HE; scale bar
100 μm) (A); CMG from control case C2 with a normal number of neurons, HE (scale bar 100 μm) (B); Ileum from case ED7 with a reduction in
nerve networks in the circular muscle (CM), myenteric plexus (MP), and longitudinal muscle (LM; from the top to bottom of image); protein gene
product 9.5 [PGP 9.5] (scale bar 50 μm) (C); Ileum from control case C3 with normal nerve networks in the CM, MP, and LM; PGP 9.5 (scale bar
50 μm) (D); Ileum from case ED7 with a normal network of interstitial cells of Cajal (ICC) in the CM, c-kit (scale bar 50 μm) (E); Ileum from control
case C2 with a normal network of ICC in the CM, c-kit (scale bar 50 μm) (F)
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muscular hypertrophy, and gastric mucosal hypertrophy (as assessed
by gross and histological examination) and ulceration. Density of neu-
rons in prevertebral and paravertebral ganglia was significantly lower
in group ED and in the intestinal tract, and the ileum was worst
affected, especially the SMP. In the ileum, group ED had significantly
less PGP 9.5 staining for neural networks in the MP and CM than con-
trols, and there was also less staining for c-kit (ICC) in the ileal MP but
not the muscularis externa. No such changes occurred in the large
F IGURE 2 Individual value plot of neuron numbers in the cranial
cervical and celiacomesenteric ganglia of groups ED and C. C, control
group; ED, equine dysautonomia group; CCG, cranial cervical
ganglion; CMG, celiacomesenteric ganglion; bar, mean value.
*P < .001 for CCG (unpaired t test) and P = .011 for CMG
(Mann-Whitney U test)
F IGURE 3 Individual value plot of neuron numbers in the
submucosal and myenteric plexus of the jejunum and ileum of groups
ED and C. C, control group; ED, equine dysautonomia group; SMP,
submucosal plexus; MP, myenteric plexus; bar, mean value. *P = .004
for ileum MP, P < .001 for ileum SMP, P = .023 for jejunum SMP
(Mann-Whitney U test)
F IGURE 4 Individual value plot of c-kit staining in the CM of the
jejunum and ileum, and the LM of the ileum of groups ED and
C. C, control group; ED, equine dysautonomia group; CM, circular
muscle; LM, longitudinal muscle; bar, mean value. P > .05 for all
comparisons between groups
F IGURE 5 Individual value plot of c-kit staining in the myenteric
plexus of the jejunum and ileum of groups ED and C. C, control group;
ED, equine dysautonomia group; bar, mean value. *P = .02 for ileum
MP (Mann-Whitney U test)
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intestine. Beta-amyloid precursor protein and ubiquitin did not show
consistent changes suggestive of neurodegeneration. The results sug-
gest that despite considerable loss of neurons in peripheral ganglia
and small intestine, the ICC network in the muscularis externa of the
small intestine is adequate. However, there is no evidence for ongoing
neurodegenerative changes as assessed by BAPP and ubiquitin expres-
sion. The ICC could provide a means for maintaining intestinal motility
in horses that have recovered from ED.
The most common residual clinical signs in recovered cases of ED
were recurrent mild colic and terminal severe colic, as previously
described.9,10 This is consistent with dilation sometimes combined
with hypertrophy of the muscularis externa, especially of the distal
jejunum and the ileum. However, 2 horses with ED had dilated small
intestine but no history of colic; therefore, either mild clinical signs
can be missed or the dilation per se is not painful in some cases. Dila-
tion can be an incidental finding or associated with postmortem gas
accumulation, but the macroscopic appearance of dilated areas in ED
cases was considered distinct from incidental changes. The degree of
dilation with turgidity of the wall and the muscular hypertrophy
observed suggested a probable chronic course, and it is possible that,
in some horses, age-related loss of neurons might have contributed to
preexisting disease-related neuronal loss, resulting in a critical thresh-
old of neuronal depletion, beyond which adequate intestinal motility
could not be maintained. However, this remains speculative. Hyper-
trophy of the muscularis externa could represent a compensatory
response to motility disturbances resulting from neuronal loss.21 It is
also feasible that muscular hypertrophy contributed to intestinal dila-
tion in cases with dilation immediately proximal to an area of hyper-
trophy/stricture or dysmotility. Ulceration of the squamous gastric
mucosa and hypertrophy of the glandular mucosa was common and
again might have resulted from poor motility resulting in delayed gas-
tric emptying. Although muscular hypertrophy of the ileum and gastric
ulceration can have other causes, association with ED was considered
likely in view of their frequency. However, association with ED is not
F IGURE 6 Celiacomesenteric ganglion (CMG) from case ED13 with normal nuclear and cytoplasmic staining of neurons for ubiquitin (A);
CMG from control case C4 with normal staining for ubiquitin (B); CMG from case ED13 with normal low staining of neurons for beta-amyloid
precursor protein (BAPP) (C); CMG from control case C4 with normal low staining for BAPP (D). Scale bars 50 μm
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proven in the present study, especially as the group sizes were small.
As expected, and consistent with the fact that large colon impaction is
a feature of acute and subacute rather than chronic ED, abnormalities
related to ED were not detected on gross or routine histological
examination of the large intestine. Similarly, IHC revealed minimal
changes in the large intestine in the recovered cases. A mild predomi-
nantly periportal inflammatory infiltrate in the liver can occur in ED22;
however, in our study, this was present to a similar extent in control
horses and is most likely to be age-related.
As previously described in ED cases at the time of clinical dis-
ease6,11,12 and in the few recovered cases previously studied,10 neu-
rons were also consistently depleted in horses after clinical recovery
from ED. Thus, our study revealed neuronal depletion in recovered
ED cases in the CCG and CMG, the SMP and MP of the ileum, and, to
a lesser extent, the SMP and MP in the jejunum. The degree of neuro-
nal loss in the ileum was marked and included horses that had few or
no residual clinical signs. The results of PGP 9.5 staining for nerve net-
works complemented the neuron counts in that a significant reduction
in expression was present in the MP of the ileum. It was also clear that
neuron counts in the LVC and SC were either unaffected or affected
to a much lesser degree.
Protein gene product 9.5, the enzyme ubiquitin carboxy-terminal
hydrolase L1, is primarily used to demonstrate neural networks. Protein
gene product 9.5 is also a cofactor for ubiquitin and together they form
part of the ubiquitin proteasome system. This pathway is involved in
degradation of nonessential and damaged proteins including BAPP23
and is defective in a variety of human neurodegenerative diseases
including Alzheimer's and Parkinson's diseases, spinal muscular atrophy,
and amyotrophic lateral sclerosis.24-27 There is a decrease in PGP 9.5
expression in both prevertebral and paravertebral ganglia from acute
and subacute ED, whereby it was hypothesized that it could contribute
to neuronal degeneration.17 Our findings are not inconsistent with this
hypothesis, but it is perhaps more likely that reduced PGP 9.5 expres-
sion might simply reflect loss of neurons and nerve networks. Regard-
ing ubiquitin, an increase in cytoplasmic and decrease in nuclear
expression occurs in the CCG of acute and subacute ED cases.18 Con-
sistent with these reports, we also identified reduced nuclear staining
intensity for ubiquitin in the SMP and MP in both jejunum and ileum
in ED compared to control cases. This could reflect the previously
reported abnormalities of the ubiquitin proteasome system in ED,18
which might ultimately contribute to the gradual decompensation of
enteric function in some cases.
Amyloid β peptide is a cleavage product of BAPP that accumulates
in the extracellular space in Alzheimer's disease.28 Beta-amyloid pre-
cursor protein increases in the perikarya of CCG neurons in acute and
subacute ED and is thought to be involved in the pathogenesis of
ED.18 The increase in BAPP staining is also of value in the antemor-
tem diagnosis of acute and subacute ED, and there is increased
expression in rectal biopsies from ED-affected horses.19 In contrast,
we found no evidence of significantly greater BAPP staining at any
site in the ED cases compared with controls; therefore, accumulation
of BAPP does not appear to be a feature of recovered ED cases. This
suggests that neuronal degeneration occurs during the earlier stages
of the disease but is not an ongoing process in recovered cases.
Of particular interest in the context of maintenance of intestinal
motility were the ICC. C-kit, a receptor tyrosine kinase, is commonly
used as a marker of ICC in a range of species. It is also expressed by
mast cells, but the typical morphology of the ICC and the usual
absence of mast cells from the MP, CM, and LM support the use of
c-kit as an ICC-specific marker in the context of this study. The ICC
numbers were significantly lower in the ileal MP in the ED group,
compared with the controls but were not significantly lower in the
ileal CM and LM. Interstitial cells of Cajal were also not significantly
depleted in the MP or CM of the jejunum. These findings create the
intriguing possibility that the presence of an adequate network of
ICC, at least in the muscularis externa, could have a role in maintaining
small intestinal motility in the face of marked neuronal depletion.16
Interstitial cells of Cajal were also significantly depleted in the MP and
CM of the SC in ED cases, but the number of samples from this site
was small, increasing the risk of type 1 errors and raising uncertainty
over its importance.
Considerable research is currently focused on the function of the
ICC and their role in human gastrointestinal diseases. The ICC are mes-
enchymal in origin and share a common progenitor with smooth muscle
cells. They form a branching network of cells in all layers from the sub-
mucosa to the serosa, including the muscle layers and MP area, from
the esophagus to the internal anal sphincter. In the CM and LM, the cells
of the ICC run parallel to the orientation of the smooth muscle cells29
and have long fiber-like projections. Interstitial cells of Cajal are known
to have a role as “pacemaker cells” and are responsible for the genera-
tion of slow waves in the intestine of many species, including humans30
and horses.14 In comparison, smooth muscle cells can show spontane-
ous activity but cannot generate slow wave activity on their own.31 The
ICC form part of a syncytium involving smooth muscle and neurons13,29
and abolition of ICC prevents slow waves in some human motility
disorders.32-34
In horses, ICC occur in the MP, CM and, in the ileum, the LM.20,35
Reduction in ICC in ileum and large colon occurs in ED, but in ileal
CM, this reduction is less in chronic than acute cases.14 in vitro electri-
cal activity can still be prominent in ED,15 a finding that may support
the continued presence of ICC-associated pacemaker activity in the
face of neuronal loss.15 It is therefore possible that the neuronal loss
in ED may not completely prevent propagation of electrical events
from the ICC to the muscular layers, thus allowing continued peristal-
tic activity in recovered cases. This is consistent with the proposal
that depletion or malfunction of 1 component of the gastrointestinal
neuromuscular system (ICC, neural, or muscular) does not necessarily
result in failure of the whole system, due to a degree of overlap in
function and the capacity for other components to compensate.34
Despite this potential for a compensatory response, it is likely that a
critical threshold exists, beyond which no further compensation is
possible, thus leading to chronic intestinal remodeling and sometimes
severe colic that may prompt euthanasia on humane grounds. These
proposals might explain how recovered ED cases can apparently
maintain function for many years but can ultimately succumb to
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critical failure, that is, acute colic requiring euthanasia. Furthermore,
ICCs possess the capacity to regenerate which could help to prolong
motility following depletion of ICC.36,37 In view of this, the ICC are
considered a promising target for the development of drug therapies
designed to maintain their function, as has been proposed in human
medicine.38
This study presented a number of challenges; in particular, obtaining
a sufficient number of well-documented recovered ED cases that ret-
urned to the Equine Hospital from a wide geographical area for post-
mortem examination, often many years after the initial diagnosis. The
original diagnoses were made by experienced clinicians on the basis of
typical clinical signs. Ideally biopsies would have been undertaken to
confirm antemortem diagnosis, but this was considered undesirable and
unnecessary on clinical grounds, and marked reduction of neurons evi-
dent many years later supports the original diagnosis. As the study was
conducted over a 15-year period, the study's pathologist was not always
available to collect samples from every case; as a result, some samples
were missing from some cases. However, this still represents the largest
and the most detailed study undertaken to date examining the pathol-
ogy of ED cases that had recovered for such a long time period.
In conclusion, the main findings during gross postmortem examina-
tion of long-term ED survivors were gastric ulceration, small intestinal
dilation, and hypertrophy of the muscularis externa, which appeared to
be of a prolonged duration. In some of the cases, these findings were
associated with chronic recurrent colic or a terminal severe colic epi-
sode. Recovered cases also had evidence of significant neuronal loss in
prevertebral and paravertebral ganglia and in the enteric plexuses of
the small intestine, particularly the ileum. However, the ICC networks
are mainly intact in the muscularis externa of the small intestine which
may contribute to the maintenance of intestinal motility in such cases.
If therapeutic strategies designed to support ICC function could be
developed in the future, this might be of value in the treatment of
chronic or recovered cases of ED.
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